Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 1,391.10
-65.55 (-4.50%)
At close: Mar 27, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 14.43 billion as of March 27, 2026. Its market cap has increased by 121.04% in one year.
Market Cap
14.43B
Enterprise Value
15.18B
Revenue
4.62B
Ranking
n/a
PE Ratio
25.56
Stock Price
1,391.10
Market Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 14.43B, an increase of 6,152.13%. That is a compound annual growth rate of 53.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 15.11B | 31.43% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 23.14B |
| Unichem Laboratories | 21.05B |
| Morepen Laboratories | 20.26B |
| Hikal | 19.97B |
| Amrutanjan Health Care | 14.94B |
| Shukra Pharmaceuticals | 14.91B |
| Lincoln Pharmaceuticals | 11.95B |
| Venus Remedies | 11.79B |